Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01651299 · ClinicalTrials.gov registry record
Copperhead Envenomation Observational Study
A clinical trial, sponsored by BTG International.
- Completed
- Registry status
- 20
- Enrollment target
NCT01651299: Completed study, sponsored by BTG International.
NCT01651299 is a clinical trial that has completed, run by BTG International. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01651299 has completed, sponsored by BTG International.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate the responsiveness and utility of several clinical outcome assessments in the setting of copperhead snakebite. The secondary objective is to characterize the clinical course of signs, symptoms and impairment during the recovery phase of copperhead snakebite.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-04 |
What the finished NCT01651299 record still lists
NCT01651299 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01651299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01651299 about?
NCT01651299 is a clinical study titled "Copperhead Envenomation Observational Study". The primary objective of the study is to evaluate the responsiveness and utility of several clinical outcome assessments in the setting of copperhead snakebite. The secondary objective is to characterize the clinical course of signs, symptoms and impairment during the recovery phase of copperhead sn...
What is the current status of trial NCT01651299?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-07. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01651299?
This trial is sponsored by BTG International, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia